Atlas FDA

CustomFlex Artificial Iris

FDA premarket approval P170039/S002 · decided 2019-10-03

Approval details

PMA number
P170039
Supplement
S002
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
CustomFlex Artificial Iris
Generic name
Artificial iris
Applicant
Humanoptics AG
Date received
2018-07-19
Decision date
2019-10-03
Days to decision
441 days
Decision code
APPR
Product code
QBT
Advisory committee
Ophthalmic
Expedited review
No
Location
Erlangen
Statement
Approval of the protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.